PMID 40439155

Research
All papers

Heterogeneous Exercise Responses to High-Intensity Interval Training Are Associated With Varied Long-Term Cardiovascular Outcomes in Patients With Heart Failure: A 15-Year Follow-Up

Question

Are heterogeneous physiological responses to supervised HIIT in patients with heart failure associated with different long-term survival and cardiovascular readmission outcomes, and which HIIT-associated adaptations mediate those outcomes?

Summary

This retrospective cohort study followed 182 patients with heart failure who completed 36 supervised in-hospital HIIT sessions. About 21% did not improve peak oxygen consumption after HIIT. Responders had larger improvements in oxygen uptake efficiency, arteriovenous oxygen difference, skeletal muscle mass, peak heart rate, and heart rate reserve, and had better long-term cardiovascular event-free survival than nonresponders.

Methodology

  • Adults with stable heart failure who completed 36 supervised in-hospital HIIT sessions in Taiwan.
  • 182 participants.
  • Bicycle ergometer.
  • Work intervals: 3 minutes at 80% VO2peak.
  • Recovery: 3 minutes at 40% VO2peak.
  • Intensity: 80% and 40% of peak oxygen consumption.
  • 30 minutes.
  • 2-3 sessions per week.
  • 36 sessions.
  • Retrospective cohort study using registry data from three Chang Gung Medical Foundation institutes, classifying heart failure patients who completed 36 HIIT sessions as responders or nonresponders by change in peak oxygen consumption.
  • Peak oxygen consumption, Cardiovascular event-free survival, Heart rate reserve, and Left ventricular geometry and function were tracked.

Outcomes

Responder prevalence

Of 182 HIIT completers, 143 were responders and 39 were nonresponders, giving a nonresponder prevalence of 21%.

Responder classification was based on post-HIIT minus baseline VO2peak greater than 0 versus 0 or less.

Mixed

Cardiovascular event-free survival

Responders had better 14-year cardiovascular event-free survival than nonresponders.

91.3% versus 76.8%, P=0.037.

Improved

Overall survival and cardiovascular readmission

Overall survival and cardiovascular readmissions were numerically better in responders but did not significantly differ across the full 14-year follow-up.

Overall survival 83.7% versus 67.2%; readmissions 36.1% versus 46.7%; both not significant.

No clear change

Cardiorespiratory fitness

Responders improved VO2peak, OUES, HRR, peak HR, and VE/VCO2 slope; nonresponders had significantly decreased VO2peak and nonsignificant adverse trends in some cardiorespiratory markers.

Post-HIIT VO2peak 5.72 MET in responders versus 4.44 MET in nonresponders, P<0.001; OUES P=0.001; peak HR P=0.005; HRR P=0.007 between groups.

Mixed

Mediation analysis

VO2peak mediated the association between HIIT and all-cause death, and HRR mediated the association between HIIT and cardiovascular readmissions.

VO2peak indirect path coefficient -30.96 (95% CI -81.05 to -2.96); HRR indirect path coefficient -2.96 (95% CI -7.81 to -0.02).

Improved

Insights

  • In clinical heart failure rehabilitation, a fixed HIIT protocol can produce heterogeneous physiological responses.
  • VO2peak and HRR are useful response markers to monitor after HIIT in heart failure populations.
  • Consumers with heart failure should not infer that unsupervised HIIT is appropriate; the evidence depends on medical screening and supervised cardiac rehabilitation.

Limitations

  • Retrospective design limits causal inference.
  • No non-HIIT control group.
  • Nonresponder sample was relatively small.
  • Only patients completing all 36 sessions were included.
  • Exact exercise volume after HIIT during follow-up was not recorded.
  • Sleep quality was not provided.
  • Some measurements had missing data.

Safety

  • The main article did not report specific adverse event counts during training.
  • Participants were clinically screened and trained under supervised in-hospital cardiac rehabilitation.
  • Patients with decompensated heart failure, severe COPD, severe renal dysfunction, noncardiac disease prohibiting cycling, or ACSM absolute exercise contraindications were excluded.